Neural and behavioral measures suggest that cognitive and affective functioning interactions mediate risk for psychosis-proneness symptoms in youth with chromosome 22q11.2 deletion syndrome.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
07 2020
Historique:
received: 31 10 2019
revised: 04 03 2020
accepted: 01 04 2020
pubmed: 23 4 2020
medline: 10 3 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

Behavioral components of chromosome 22q11.2 deletion syndrome (22q), caused by the most common human microdeletion, include cognitive and adaptive functioning impairments, heightened anxiety, and an elevated risk of schizophrenia. We investigated how interactions between executive function and the largely overlooked factor of emotion regulation might relate to the incidence of symptoms of psychotic thinking in youth with 22q. We measured neural activity with event-related potentials (ERPs) in variants of an inhibitory function (Go/No-Go) experimental paradigm that presented affective or non-affective stimuli. The study replicated inhibition impairments in the 22q group that were amplified in the presence of stimuli with negative, more than positive affective salience. Importantly, the anterior N2 conflict monitoring ERP significantly increased when youth with 22q viewed angry and happy facial expressions, unlike the typically developing participants. This suggests that youth with 22q may require greater conflict monitoring resources when controlling their behavior in response to highly salient social signals. This evidence of both behavioral and neurophysiological differences in affectively influenced inhibitory function suggests that frequently anxious youth with 22q may struggle more with cognitive control in emotionally charged social settings, which could influence their risk of developing symptoms of psychosis.

Identifiants

pubmed: 32319730
doi: 10.1002/ajmg.a.61596
pmc: PMC9196260
mid: NIHMS1794655
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1615-1630

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD103526
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107108
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD079125
Pays : United States
Organisme : NIH HHS
ID : R01-MH107018
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

J Dev Behav Pediatr. 2012 Nov-Dec;33(9):713-20
pubmed: 23117596
Am J Intellect Dev Disabil. 2019 Nov;124(6):549-567
pubmed: 31756146
Am J Psychiatry. 2005 Jun;162(6):1090-9
pubmed: 15930057
Am J Psychiatry. 2014 Jun;171(6):627-39
pubmed: 24577245
Am J Psychiatry. 2007 Apr;164(4):663-9
pubmed: 17403981
Schizophr Res. 2017 Oct;188:42-49
pubmed: 28041919
Nat Rev Neurosci. 2000 Oct;1(1):59-65
pubmed: 11252769
Front Psychiatry. 2013 Aug 07;4:81
pubmed: 23966958
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
J Cogn Neurosci. 2011 Sep;23(9):2123-34
pubmed: 20809855
Lancet. 2007 Oct 20;370(9596):1443-52
pubmed: 17950858
Am J Med Genet B Neuropsychiatr Genet. 2007 Jan 5;144B(1):27-36
pubmed: 17034021
Dev Disabil Res Rev. 2008;14(1):52-8
pubmed: 18612330
Eur J Hum Genet. 2016 Jun;24(6):844-51
pubmed: 26508576
Br J Psychiatry. 2005 Feb;186:115-20
pubmed: 15684233
J Anxiety Disord. 2009 Dec;23(8):1132-8
pubmed: 19695828
Schizophr Res. 2011 Jun;129(1):42-6
pubmed: 21511440
Schizophr Res. 2005 Nov 1;79(1):117-25
pubmed: 16276559
J Autism Dev Disord. 2017 Apr;47(4):992-1005
pubmed: 28083777
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Cereb Cortex. 2011 Apr;21(4):911-9
pubmed: 20732901
Brain Res Cogn Brain Res. 2005 Feb;22(2):221-31
pubmed: 15653295
Curr Psychiatry Rep. 2008 Apr;10(2):148-57
pubmed: 18474208
Curr Opin Neurobiol. 2010 Apr;20(2):236-41
pubmed: 20167473
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1060-1068
pubmed: 19797984
Front Hum Neurosci. 2014 Apr 14;8:213
pubmed: 24782741
Biol Psychol. 2009 Mar;80(3):333-8
pubmed: 19103249
Dev Psychopathol. 2005 Summer;17(3):753-84
pubmed: 16262991
Soc Cogn Affect Neurosci. 2015 Apr;10(4):577-83
pubmed: 25062842
Front Psychol. 2011 Mar 16;2:39
pubmed: 21716604
Behav Brain Res. 2015 Jan 1;276:190-8
pubmed: 24906195
J Cogn Neurosci. 1997 Nov;9(6):835-47
pubmed: 23964603
Behav Res Ther. 1998 May;36(5):545-66
pubmed: 9648330
Clin Neurophysiol. 2009 Mar;120(3):505-10
pubmed: 19157974
Psychiatry Res. 2010 May 15;177(1-2):211-5
pubmed: 20381171
J Abnorm Psychol. 2001 Feb;110(1):40-8
pubmed: 11261398
Psychophysiology. 2017 Jan;54(1):146-157
pubmed: 28000253
Psychiatry Res. 2009 Aug 15;168(3):242-9
pubmed: 19564050
Schizophr Res. 2007 May;92(1-3):168-80
pubmed: 17399952
J Neurodev Disord. 2011 Mar;3(1):68-75
pubmed: 21475728
J Am Acad Child Adolesc Psychiatry. 2013 Nov;52(11):1192-1203.e3
pubmed: 24157393
Transl Psychiatry. 2017 Jul 25;7(7):e1180
pubmed: 28742080
Biol Psychiatry. 2006 May 1;59(9):863-71
pubmed: 16325151
Psychol Rev. 2004 Oct;111(4):931-959
pubmed: 15482068
Schizophr Res. 2019 Apr;206:386-393
pubmed: 30414720
Dev Disabil Res Rev. 2008;14(1):3-10
pubmed: 18636631
Front Psychol. 2014 Jun 10;5:566
pubmed: 24959159
Trends Cogn Sci. 2004 Dec;8(12):539-46
pubmed: 15556023
Eur Child Adolesc Psychiatry. 2012 Jul;21(7):379-85
pubmed: 22526976
Brain Cogn. 2004 Nov;56(2):165-76
pubmed: 15518933
J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1104-1113
pubmed: 16926618
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
Neuropsychologia. 2010 Jul;48(9):2488-95
pubmed: 20434466
Am J Psychiatry. 2003 Apr;160(4):636-45
pubmed: 12668349
Psychol Rev. 2001 Jul;108(3):624-52
pubmed: 11488380
J Affect Disord. 2012 Feb;136(3):222-8
pubmed: 21215459
Prenat Diagn. 2015 Aug;35(8):801-9
pubmed: 25962607
J Intellect Disabil Res. 2007 Sep;51(Pt 9):666-70
pubmed: 17845235
Psychophysiology. 2008 Jan;45(1):152-70
pubmed: 17850238
Dev Sci. 2005 Jan;8(1):36-43
pubmed: 15647065
JAMA Psychiatry. 2015 Apr;72(4):377-85
pubmed: 25715178
J Int Neuropsychol Soc. 2009 May;15(3):331-43
pubmed: 19402919

Auteurs

Samantha R Linton (SR)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
MIND Institute, University of California, Davis, Sacramento, California, USA.

Abbie M Popa (AM)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
MIND Institute, University of California, Davis, Sacramento, California, USA.

Steven J Luck (SJ)

Center for Mind and Brain and Department of Psychology, University of California, Davis, Davis, California, USA.

Khalima Bolden (K)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
Imaging Research Center, University of California, Davis, Sacramento, California, USA.

Cameron S Carter (CS)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
Imaging Research Center, University of California, Davis, Sacramento, California, USA.

Tara A Niendam (TA)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
Imaging Research Center, University of California, Davis, Sacramento, California, USA.

Tony J Simon (TJ)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, Sacramento, California, USA.
MIND Institute, University of California, Davis, Sacramento, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH